Stereotaxis (NYSEAMERICAN:STXS) Given New $3.00 Price Target at TD Cowen

Posted by on Aug 12th, 2026

Stereotaxis (NYSEAMERICAN:STXS – Get Free Report) had its price target dropped by analysts at TD Cowen from $5.00 to $3.00 in a note issued to investors on Wednesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. TD Cowen’s price objective suggests a potential upside of 118.18% from the company’s previous close.

A number of other research firms have also recently issued reports on STXS. Piper Sandler restated an “overweight” rating and set a $3.50 price target (down from $4.00) on shares of Stereotaxis in a report on Wednesday, May 13th. Citigroup reissued a “market outperform” rating on shares of Stereotaxis in a research report on Wednesday, June 3rd. Five research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average target price of $3.70.

View Our Latest Stock Analysis on STXS

Stereotaxis Price Performance

Shares of NYSEAMERICAN STXS traded down $0.09 during trading hours on Wednesday, hitting $1.38. 696,919 shares of the stock were exchanged, compared to its average volume of 604,006. Stereotaxis has a one year low of $1.24 and a one year high of $3.59. The company’s 50 day moving average is $1.63 and its 200 day moving average is $1.87. The firm has a market capitalization of $134.65 million, a P/E ratio of -5.73 and a beta of 1.37.

Hedge Funds Weigh In On Stereotaxis

Institutional investors and hedge funds have recently bought and sold shares of the stock. Bank of New York Mellon Corp acquired a new position in Stereotaxis during the 2nd quarter valued at $364,000. Sei Investments Co. grew its position in Stereotaxis by 108.9% in the 1st quarter. Sei Investments Co. now owns 518,884 shares of the company’s stock worth $955,000 after purchasing an additional 270,443 shares during the last quarter. Sequoia Financial Advisors LLC bought a new position in shares of Stereotaxis during the 1st quarter worth about $700,000. Bridgeway Capital Management LLC increased its holdings in shares of Stereotaxis by 56.6% during the 4th quarter. Bridgeway Capital Management LLC now owns 221,475 shares of the company’s stock worth $509,000 after purchasing an additional 80,075 shares during the period. Finally, Schonfeld Strategic Advisors LLC raised its position in shares of Stereotaxis by 47.0% during the fourth quarter. Schonfeld Strategic Advisors LLC now owns 17,801 shares of the company’s stock valued at $41,000 after buying an additional 5,692 shares during the last quarter. Institutional investors own 45.35% of the company’s stock.

About Stereotaxis

(Get Free Report)

Stereotaxis, Inc is a medical device company that develops and commercializes robotic magnetic navigation systems for use in electrophysiology procedures. Its core technology leverages precisely controlled magnetic fields to guide ultra-thin, magnetically enabled catheters through the vascular system, allowing physicians to perform complex cardiac ablation and diagnostic procedures with enhanced precision and stability. This platform aims to reduce procedure times and radiation exposure for both patients and clinical staff.

The company’s flagship offering, the Niobe Magnetic Navigation System, integrates with a variety of catheter types and electrophysiology mapping systems to support treatment of arrhythmias such as atrial fibrillation and ventricular tachycardia.

Featured Articles

Analyst Recommendations for Stereotaxis (NYSEAMERICAN:STXS)

Receive News & Ratings for Stereotaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stereotaxis and related companies with MarketBeat.com's FREE daily email newsletter.